In one paragraphArticle in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors at 4 institutions in 1 country.
Chuancang JiangSomatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.
Ming-Lang ZhaoSomatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.ORCID 0000-0002-6916-2003 Katarzyna DobaczewskaMicroscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-6377-018X Ronald HerbertCellular and Molecular Pathology, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC.ORCID 0000-0003-3310-7843 Zbigniew MikulskiMicroscopy and Histology Core Facility, La Jolla Institute for Immunology, La Jolla, CA.ORCID 0000-0002-1918-9216 Laurent VerkoczySan Diego Biomedical Research Institute, San Diego, CA mdiaz@sdbri.org lverkoczy@sdbri.org.
Marilyn DiazSomatic Hypermutation Group, Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC mdiaz@sdbri.org lverkoczy@sdbri.org.ORCID 0000-0002-3046-2746 National Institutes of Health · USLa Jolla Institute for Immunology · USSan Diego Biomedical Research Institute · USTriangle · US
Funding
Somatic HypermutationZIAES101603 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI DIAZ, MARILYN · 2009 to 2014
$9.7MSomatic HypermutationZ01ES101603 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI DIAZ, MARILYN · 2003 to 2008
$2.8MIntramural NIH HHS Z01 ES101603Intramural NIH HHS ZIA ES101603
6 · The paper itselfAbstract
MRL/lpr mice typically succumb to immune complex-mediated nephritis within the first year of life. However, MRL/lpr mice that only secrete IgM Abs because of activation-induced deaminase deficiency (AID
Indexed as
Adoptive TransferAICDA (Activation-Induced Cytidine Deaminase)AnimalsAntibodies, AntinuclearAutoimmunityB-LymphocytesCytidine DeaminaseDisease Models, AnimalImmunoglobulin MLymphoma, Large-Cell, AnaplasticMaleMiceMice, Inbred C57BLMice, Inbred MRL lprMice, KnockoutT-LymphocytesAICDA (Activation-Induced Cytidine Deaminase)Antibodies, Antinuclearanti-dsDNA autoantibodyanti-small nuclear ribonucleoproteins autoantibodiesCytidine DeaminaseImmunoglobulin Msecretory IgMTrp53 protein, mouseTumor Suppressor Protein p53
Identifiers
PMID33883189
PMCPMC8113120
OpenAlexW3152989625
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390